Pulike Biological Engineering603566
▼ NegativeCapitalrelevance
Net profit fell 33.45% and revenue declined 12.18% in the interim report.
Impact on stocks 1
Others
Pulike Biological EngineeringPulike released its 2026 interim report, with net profit attributable to the parent company of 77.32 million yuan, down 33.45% from the same period last year. Total operating revenue was 491 million yuan, down 12.18% year on year. Net cash inflow from operating activities was 78.07 million yuan, down 59.98% year on year. The latest gross margin was 55.76%, down 4.01 percentage points from a year earlier. Diluted earnings per share were 0.23 yuan, down 32.35% year on year.
Pulike Biological EngineeringNet profit fell 33.45% and revenue declined 12.18% in the interim report.